Michelis, F V <br/><br/>
Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.  [electronic resource] 

 -  Bone marrow transplantation  Nov 2015 
 - 1405-10 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2015.165  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Aged<br/>Allografts<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Combined Modality Therapy<br/>Comorbidity<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leukemia, Myeloid, Acute--mortality<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--mortality<br/>Prognosis<br/>Recurrence<br/>Remission Induction<br/>Retrospective Studies<br/>Salvage Therapy<br/>Severity of Illness Index<br/>Transplantation Conditioning<br/>Young Adult